IFM Therapeutics' Series A Round

IFM Therapeutics raised a round of funding on June 22, 2016.

IFM Therapeutics is a biopharmaceutical company developing a portfolio of first-in-class small molecules targeting the innate immune system. IFM Therapeutics is developing modulators of novel targets …

Articles about IFM Therapeutics' Series A Round: